NFKB1 and neoplasm: To elucidate the structural basis of the binding of EriB with p50, in our present study, EBF7, dansyl EriB with α, β-unsaturated ketones reduced was created, which, as expected, lost the anti-tumor activity in vitro (IC50>35 μM in MTT assay) (Figure 2).